Search

everythinglearnresearchcommunity

for

Search:↓

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

New effective scar treatments are urgently needed due to the current options' limited success.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

New treatments for acne scars are safer and more effective because we understand the causes better.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Surgical removal of a scalp keratoacanthoma is effective and prevents recurrence, but hair may not regrow.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.